PL360470A1 - Lipozomalne kompozycje zawierające beznochinazolinowe inhibitory syntazy tymidylanowej - Google Patents

Lipozomalne kompozycje zawierające beznochinazolinowe inhibitory syntazy tymidylanowej

Info

Publication number
PL360470A1
PL360470A1 PL36047001A PL36047001A PL360470A1 PL 360470 A1 PL360470 A1 PL 360470A1 PL 36047001 A PL36047001 A PL 36047001A PL 36047001 A PL36047001 A PL 36047001A PL 360470 A1 PL360470 A1 PL 360470A1
Authority
PL
Poland
Prior art keywords
liposomal
synthase inhibitor
thymidylate synthase
inhibitor formulations
benzoquinazoline thymidylate
Prior art date
Application number
PL36047001A
Other languages
English (en)
Inventor
Claudien S. Ashvar
Su-Ming Chiang
David L. Emerson
Ning Hu
Gerard M. Jensen
Original Assignee
Osi Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osi Pharmaceuticals, Inc. filed Critical Osi Pharmaceuticals, Inc.
Publication of PL360470A1 publication Critical patent/PL360470A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL36047001A 2000-06-09 2001-06-06 Lipozomalne kompozycje zawierające beznochinazolinowe inhibitory syntazy tymidylanowej PL360470A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21059200P 2000-06-09 2000-06-09

Publications (1)

Publication Number Publication Date
PL360470A1 true PL360470A1 (pl) 2004-09-06

Family

ID=22783495

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36047001A PL360470A1 (pl) 2000-06-09 2001-06-06 Lipozomalne kompozycje zawierające beznochinazolinowe inhibitory syntazy tymidylanowej

Country Status (15)

Country Link
US (2) US6689381B2 (pl)
EP (1) EP1286661A2 (pl)
JP (1) JP2004503491A (pl)
KR (1) KR100851957B1 (pl)
CN (1) CN1446080A (pl)
AU (2) AU7526901A (pl)
BR (1) BR0111541A (pl)
CA (1) CA2412165A1 (pl)
IL (2) IL153230A0 (pl)
MX (1) MXPA02012068A (pl)
NZ (1) NZ522842A (pl)
PL (1) PL360470A1 (pl)
TW (1) TWI282741B (pl)
WO (1) WO2001095884A2 (pl)
ZA (1) ZA200209524B (pl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
JP2005529076A (ja) 2002-02-15 2005-09-29 サイトキネティクス・インコーポレーテッド キナゾリノンの合成
RU2004135554A (ru) 2002-05-09 2006-01-20 Цитокинетикс, Инк. (Us) Пиримидиноны, композиции на их основе и способы их использования
EP1553931A4 (en) 2002-05-09 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1513820A4 (en) 2002-05-23 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
CA2489367A1 (en) 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
EP1537089A4 (en) 2002-07-23 2008-04-16 Cytokinetics Inc CONNECTIONS, COMPOSITIONS AND PROCEDURES
WO2004034972A2 (en) 2002-09-30 2004-04-29 Cytokinetics, Inc. Compounds, compositions, and methods
AU2003298738A1 (en) * 2002-11-26 2004-06-18 Su-Ming Chiang Liposomal formulations
EP1692112A4 (en) 2003-12-08 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS, AND METHODS
AU2005206163B2 (en) * 2004-01-14 2011-06-30 Gilead Sciences, Inc. Lipid-based dispersions useful for drug delivery
US20060051406A1 (en) * 2004-07-23 2006-03-09 Manjeet Parmar Formulation of insoluble small molecule therapeutics in lipid-based carriers
WO2006014035A1 (en) * 2004-08-06 2006-02-09 Biospectrum, Inc. Multiple layered liposome and preparation method thereof
US20080213345A1 (en) * 2004-09-13 2008-09-04 Gilead Sciences, Inc. Delivering Iron to an Animal
US20060159735A1 (en) * 2005-01-20 2006-07-20 Nicholas Bonham Method of reclaiming drug compound from liposomal drug manufacturing stream
WO2006078253A1 (en) * 2005-01-20 2006-07-27 Osi Pharmaceuticals, Inc. Method of reclaiming drug compound osi-7904 from liposomal drug manufacturing stream
EP1745788A1 (de) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
CN100348194C (zh) * 2005-07-26 2007-11-14 康辰医药发展有限公司 盐酸洛拉曲克的脂质体制剂及其制备方法
CA2631875A1 (en) * 2005-12-06 2007-10-04 Rigel Pharmaceuticals, Inc. Formulation of insoluble small molecule therapeutics in lipid-based carriers
US9493810B2 (en) * 2012-06-07 2016-11-15 Pioma, Inc. 5-ALA for detection of brain tumors
EP2874605A1 (en) * 2012-07-18 2015-05-27 Onyx Therapeutics, Inc. Liposomal compositions of epoxyketone-based proteasome inhibitors
WO2018031968A1 (en) 2016-08-12 2018-02-15 L.E.A.F. Holdings Group Llc Alpha and gamma-d polyglutamated antifolates and uses thereof
CN121177507A (zh) 2016-08-12 2025-12-23 L.E.A.F.控股集团公司 α和γ-D聚谷氨酸化抗叶酸剂及其用途
US12310966B2 (en) 2018-02-07 2025-05-27 L.E.A.F. Holdings Group Llc Alpha polyglutamated aminopterin and uses thereof
US12220431B2 (en) 2018-02-07 2025-02-11 L.E.A.F. Holdings Group Llc Gamma polyglutamated antifolates and uses thereof
WO2019157121A1 (en) 2018-02-07 2019-08-15 L.E.A.F. Holdings Group Llc Alpha polyglutamated lometrexol and uses thereof
WO2019157145A1 (en) 2018-02-07 2019-08-15 L.E.A.F. Holdings Group Llc Gamma polyglutamated pemetrexed and uses thereof
JP7491572B2 (ja) 2018-02-07 2024-05-28 エル．イー．エー．エフ． ホールディングス グループ エルエルシー アルファポリグルタミン酸化ペメトレキセドおよびその使用
EP3749319A4 (en) 2018-02-07 2022-06-22 L.E.A.F Holdings Group LLC TETRAHYDROFOLATES ALPHA POLYGLUTAMATE AND THEIR USES
CN111867593A (zh) 2018-02-07 2020-10-30 L.E.A.F.控股集团公司 α聚谷氨酸化抗叶酸剂及其用途
EP3749318A4 (en) 2018-02-07 2022-07-06 L.E.A.F Holdings Group LLC GAMMA-POLYGLUTAMATED RALTITREXED AND ITS USES
EP3749314A4 (en) 2018-02-07 2022-02-23 L.E.A.F Holdings Group LLC ALPHA-POLYGLUTAMATE METHOTREXATE AND ITS USES
CA3090389A1 (en) 2018-02-07 2019-08-15 L.E.A.F. Holdings Group Llc Alpha polyglutamated raltitrexed and uses thereof
WO2019157129A1 (en) 2018-02-07 2019-08-15 L.E.A.F. Holdings Group Llc Alpha polyglutamated pralatrexate and uses thereof
CA3090753A1 (en) 2018-02-14 2019-08-22 L.E.A.F. Holdings Group Llc Gamma polyglutamated pralatrexate and uses thereof
US12350271B2 (en) 2018-02-14 2025-07-08 L.E.A.F. Holdings Group Llc Gamma polyglutamated aminopterin and uses thereof
WO2019160735A1 (en) 2018-02-14 2019-08-22 L.E.A.F. Holdings Group Llc Gamma polyglutamated tetrahydrofolates and uses thereof
JP7462950B2 (ja) 2018-02-14 2024-04-08 エル．イー．エー．エフ． ホールディングス グループ エルエルシー ガンマポリグルタミン酸化メトトレキセートおよびその使用
WO2019160734A1 (en) 2018-02-14 2019-08-22 L.E.A.F. Holdings Group Llc Gamma polyglutamated lometrexol and uses thereof
WO2025095862A1 (en) * 2023-10-30 2025-05-08 National University Of Singapore A composition, a method of making the composition and its uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460577A (en) * 1977-09-30 1984-07-17 Farmitalia Carlo Erba S.P.A. Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4755388A (en) * 1984-11-09 1988-07-05 The Regents Of The University Of California Liposome-encapsulated 5-fluoropyrimidines and methods for their use
US4753788A (en) 1985-01-31 1988-06-28 Vestar Research Inc. Method for preparing small vesicles using microemulsification
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
WO1994011030A1 (en) 1992-11-13 1994-05-26 The Ohio State University Research Foundation C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide
JPH11199488A (ja) * 1998-01-09 1999-07-27 Sankyo Co Ltd 抗腫瘍薬のリポソーム化製剤

Also Published As

Publication number Publication date
JP2004503491A (ja) 2004-02-05
WO2001095884A2 (en) 2001-12-20
US20040057990A1 (en) 2004-03-25
CN1446080A (zh) 2003-10-01
NZ522842A (en) 2004-11-26
TWI282741B (en) 2007-06-21
KR20030038552A (ko) 2003-05-16
AU2001275269B2 (en) 2006-07-13
KR100851957B1 (ko) 2008-08-12
ZA200209524B (en) 2003-11-22
EP1286661A2 (en) 2003-03-05
MXPA02012068A (es) 2004-08-19
BR0111541A (pt) 2003-07-01
IL153230A0 (en) 2003-07-06
IL153230A (en) 2009-02-11
US20020034538A1 (en) 2002-03-21
WO2001095884A3 (en) 2002-06-13
US6689381B2 (en) 2004-02-10
CA2412165A1 (en) 2001-12-20
AU7526901A (en) 2001-12-24

Similar Documents

Publication Publication Date Title
AU7526901A (en) Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
AU2001258771A1 (en) -secretase inhibitors
GB2359254B (en) Formulation
SI1263740T1 (sl) Derivati spojine pirimidin-4-on kot inhibitorji ldl-pla2
AU2001237041A1 (en) Kinase inhibitors
AU3704101A (en) Kinase inhibitors
GB0000891D0 (en) Formulation
AU9052201A (en) Methyl-d-erythritol phosphate pathway genes
AU2001236052A1 (en) Urease inhibitors
AU2002222627A1 (en) Tak1 inhibitors
GB0001539D0 (en) Amplifiers
GB0030284D0 (en) Enzyme inhibitors
AU4341401A (en) Opioid formulations
AU2002233244A1 (en) Anti-corrosion agents
AU2001269121A1 (en) Substituted amidoalkyl-uracils as parp inhibitors
TW418747U (en) Wrench
GB0229613D0 (en) Biocatalyst inhibitors
HK1052294A (en) Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
GB2371255B (en) Spanner
AU2001263003A1 (en) Carboxyalkylether-acat inhibitor combinations
AU2001268051A1 (en) Spla2 inhibitors
GB0015996D0 (en) Inhibitors
GB0021193D0 (en) Inhibitors
GB0029733D0 (en) Inhibitors
GB0029730D0 (en) Inhibitors

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)